APG vs LII

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and a missing Altman Z-Score prevents a full solvency assessment. Despite strong recent price performance and robust revenue and earnings growth, the stock trades at a steep valuation (P/E of 116.19 vs. sector average of 48.97) far above its Graham Number of $7.99 and intrinsic value of $10.62, suggesting significant overvaluation. Earnings quality is deteriorating, with 3 of the last 4 quarters missing estimates by an average of -32.33%, and YoY EPS has declined by 41.2% despite positive Q/Q growth. Heavy insider selling of $20.69M in the last 6 months and a bearish technical trend further reinforce caution.

LII exhibits significant financial deterioration, highlighted by a weak Piotroski F-Score of 3/9 and a massive valuation gap where the current price ($495.52) trades at a severe premium to both its Graham Number ($130.92) and Intrinsic Value ($159.53). While the company maintains high ROE and profitability, these are offset by negative YoY revenue (-11.20%) and earnings growth (-17.90%). The combination of bearish insider sentiment, a failing technical trend, and poor liquidity (Quick Ratio 0.52) suggests a high risk of price correction.